menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
ReachMD Faculty

Public Profile

Frederick Vivino, MD
Frederick Vivino, MD

      Dr. Frederick Vivino is a clinical associate professor of medicine at the University of Pennsylvania School of Medicine, chief of the division of rheumatology at Penn Presbyterian Medical Center and director of the Penn Sjogren's Syndrome Center.

      Dr. Vivino received his MD degree from Temple University School of Medicine in 1983 and did his residency in medicine at the Medical College of Pennsylvania-Allegheny University of the Health Sciences (1983-86).  Dr. Vivino completed a fellowship in adult and pediatric rheumatology at the University of Pennsylvania School of Medicine (1986-89).  He received postgraduate research training as an associate scientist at the Wistar Institute, Philadelphia (1987-89) and is a former John A. Hartford foundation fellow.

      Dr. Vivino has served as a member of many boards and societies including the American Medical Association, the American College of Physicians, the American College of Rheumatology, the Sjogren's Syndrome Foundation, the College of Physicians of Philadelphia and the Philadelphia Regional Chapter of the Sjogren's Syndrome Foundation. He currently chairs the medical and scientific advisory board of the Sjogren's Syndrome Foundation.

      He has been recognized 4 times as a "Top Doc" by Philadelphia magazine.  He received the meritorious award for distinguished service from the American Academy of Oral Medicine in 1990 and the physician leadership award from the Sjogren's Syndrome Foundation in 2005.  He is the former medical editor of the Sjogren's Quarterly.

      Widely recognized in his field, Dr. Vivino has published numerous articles and presented internationally on the results of his Sjogren's syndrome research. His areas of interest include: Novel treatments for Sjogren's syndrome dry eyes and dry mouth, Salivary scintigraphy as an outcome measure in Sjogren's syndrome, neurocognitive dysfunction in Sjogren's syndrome, and histochemical features of the nonautoimmune sicca syndrome "chronic sialadenitis."

         

        Schedule19 Apr 2024